Senior insider sale
EVP Research & Development at CYTOKINETICS INC — senior position signals high conviction
$2.35M
36.94K shares
What this filing means
MALIK FADY IBRAHAM plans to sell 36.94K shares of CYTOKINETICS INC valued at approximately $2.35M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 4/7/2026ACC: 0001950047-26-003289
Officer· EVP Research & Development
Since Jul 2018
36.94K
Shares to sell
$2.35M
Approx. market value
22K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Exercise of Stock Options
Cash
4/7/2026
22KTotal acquired22K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
4/7/2026 | Exercise of Stock Options Cash | 22K | — |
| Total | 22K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
12.03K
Market value
$747.9K
3/17/2026
—Completed
Units to sell
2.91K
Market value
$176.5K
3/9/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
22K
Market value
$1.43M
4/7/2026
Total
Units
36.94K
Value
$2.35M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
3/17/2026 | 12.03K | $747.9K | — | Completed |
3/9/2026 | 2.91K | $176.5K | — | Completed |
| Planned — Approximate Date | ||||
4/7/2026 | 22K | $1.43M | NASDAQ | Planned |
| Total | 36.94K | $2.35M | ||